Greater Treatment Benefit With Omalizumab in Children With Increased Asthma Severity: Exploratory Analyses From the Inner-City Anti-IgE Therapy for Asthma (ICATA) Study

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2017.12.045
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Rationale for Treating Allergic Asthma With Anti-IgE

European Respiratory Review
PulmonaryRespiratory Medicine
2007English

Anti- IgE Treatment in Asthma: Is Atopy Essential?

World Allergy Organization Journal
ImmunologyPulmonaryAllergyRespiratory Medicine
2015English

Inner City Asthma

Immunology and Allergy Clinics of North America
AllergyImmunology
2015English

Appropriate Selection for Omalizumab Treatment in Patients With Severe Asthma?

European Clinical Respiratory Journal
2017English

Omalizumab Treatment in Brittle Asthma

Postepy Dermatologii I Alergologii
DermatologyAllergyImmunology
2014English

Nitrogen Dioxide Exposure in School Classrooms of Inner-City Children With Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2018English

Home Indoor Pollutant Exposures Among Inner-City Children With and Without Asthma

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
2007English

Omalizumab in the Treatment of Severe Allergic (IgE-mediated) Asthma: An Update on Recent Developments

Clinical and Translational Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2013English

Reduced Asthma Exacerbations and Asthma-Related Healthcare Resource Use With Omalizumab From the Real-World PROSPERO Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy